Giuliano Costa (@costagiuliano90) 's Twitter Profile
Giuliano Costa

@costagiuliano90

MD | Interventional cardiologist and researcher | AOU “Policlinico G. Rodolico-San Marco”, Catania, Italy

ID: 1190954041100185600

calendar_today03-11-2019 11:29:16

137 Tweet

65 Followers

58 Following

Marco Barbanti (@barbanti_marco) 's Twitter Profile Photo

1-year outcomes OPERA-TAVI registry finally out! 👉 No differences in mortality and re-hosp 👉Higher disabling stroke in Evolut PRO/PRO+ (2.6% vs. 0.4%). Selection bias? Real THV effect? It is time for more RCTs! #TAVI EuroIntervention Giuliano Costa eurointervention.pcronline.com/article/one-ye…

PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

What you should know about the OPERA-#TAVI registry just published in EuroIntervention and presented at #PCRLV 2023! 🎥 Chiara De Biase interviewed first author Giuliano Costa

Jonathan Curio (@curiojonathan) 's Twitter Profile Photo

#PCRLV 2023 may be over, but the #science is here to stay⭐️ If busy again back home, here a handy overview of the results of the presented #TopLateBreakers ⤵️ Presented by: Philipp Lurz G.Nickenig, P.Nicz, @stolz_l G.Costa

#PCRLV 2023 may be over, but the #science is here to stay⭐️

If busy again back home, here a handy overview of the results of the presented #TopLateBreakers ⤵️

Presented by: <a href="/PhilippLurz/">Philipp Lurz</a> G.Nickenig, P.Nicz, @stolz_l G.Costa
Tobias Rheude (@trheude) 's Twitter Profile Photo

Our recent study on PCI timing strategies in patients undergoing TAVI was among the most impactful articles in EuroIntervention 2023! Great collaborative work! This is a tribute to all co-workers involved in this project ! Marco Barbanti Giuliano Costa Michael Joner

Our recent study on PCI timing strategies in patients undergoing TAVI was among the most impactful articles in EuroIntervention 2023! 

Great collaborative work! This is a tribute to all co-workers involved in this project ! <a href="/barbanti_marco/">Marco Barbanti</a> <a href="/costagiuliano90/">Giuliano Costa</a> <a href="/MichaelJoner3/">Michael Joner</a>
Marco Barbanti (@barbanti_marco) 's Twitter Profile Photo

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters JACC Journals

In the RE-ACCESS 2 Study unsuccessful coronary cannulation after #Evolut and #Acurate implanted with commissural alignment was 5.5%. Acurate still better than Evolut, but Remarkable improvement compared with RE-ACCESS.Commissural alignment in #TAVI matters <a href="/JACCJournals/">JACC Journals</a>
JACC Journals (@jaccjournals) 's Twitter Profile Photo

Self-expanding (SE) Evolut PRO vs balloon-expandable (BE) SAPIEN ULTRA in small annuli: 🔸 SE - superior hemodynamic performance (gradients, PPM) 🔸 BE - less PVL, PPI, stroke 📎 bit.ly/3vntMHB #JACCINT #vhdAS #TAVI

Self-expanding (SE) Evolut PRO vs balloon-expandable (BE) SAPIEN ULTRA in small annuli:
🔸 SE - superior hemodynamic performance (gradients, PPM)
🔸 BE - less PVL, PPI, stroke

📎 bit.ly/3vntMHB #JACCINT #vhdAS #TAVI
JACC Journals (@jaccjournals) 's Twitter Profile Photo

"RE-ACCESS 2" study reveals insights into coronary cannulation post-TAVR with self-expanding devices. 5.5% faced issues, mainly with Evolut THVs. Commissural alignment crucial! bit.ly/3vwb9l6 #JACCINT #Cardiology #TAVR #cvCAD

"RE-ACCESS 2" study reveals insights into coronary cannulation post-TAVR with self-expanding devices. 5.5% faced issues, mainly with Evolut THVs. Commissural alignment crucial! bit.ly/3vwb9l6

#JACCINT #Cardiology #TAVR #cvCAD
Philippe Pibarot (@ppibarot) 's Twitter Profile Photo

This propensity-score matched study may be a foretaste of the SMART trial that will be presented at ACC this week. Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…

This propensity-score matched study may be a foretaste of the SMART trial that will be presented at ACC this week.  Evolut PRO and SAPIEN ULTRA Performance in Small Aortic Annuli: The OPERA-TAVI Registry | JACC: Cardiovascular Interventions jacc.org/doi/10.1016/j.…
Jannik Sinner (@janniksin) 's Twitter Profile Photo

A special day for me, my first Roland Garros semifinal, and to reach the ranking of world #1. Grateful for this moment, something we have worked very hard for, but the work doesn’t stop here, forza!!! 1️⃣🦊

A special day for me, my first Roland Garros semifinal, and to reach the ranking of world #1.

Grateful for this moment, something we have worked very hard for, but the work doesn’t stop here, forza!!!

1️⃣🦊
CircInterventions (@circintv) 's Twitter Profile Photo

Is there a simplified left atrial appendage closure pathway? Safety and efficacy of percutaneous closure without preprocedural imaging. A Research Letter Giuliano Costa george ramsay Claudio Sanfilippo Marco Barbanti #cardiotwitter #AHAJournals ahajrnls.org/3XDBKZb

EuroIntervention (@eurointerventio) 's Twitter Profile Photo

Early discharge after uncomplicated TAVI could be the future standard, as Bagur et al. confirm its safety and feasibility. Tailored protocols and monitoring are key. Editorial perspective by Giuliano Costa Sofia Sammartino 👉👉 shorturl.at/f3gMA #TAVR #CardiologyInnovation

Early discharge after uncomplicated TAVI could be the future standard, as Bagur et al. confirm its safety and feasibility. Tailored protocols and monitoring are key. Editorial perspective by <a href="/costagiuliano90/">Giuliano Costa</a> <a href="/ssammartino98/">Sofia Sammartino</a> 👉👉 shorturl.at/f3gMA

#TAVR #CardiologyInnovation
Giuliano Costa (@costagiuliano90) 's Twitter Profile Photo

Mitral ViV replacement with S3U under local anaesthesia and no pacing. Immediate recovery and NDD! CTA planned and #Acunav ICE-guided trans-septal puncture #CVT #CataniaValveTheraphies Edwards TAVR Edwards Lifesciences Marco Barbanti

Antonio Greco (@agrecomd) 's Twitter Profile Photo

Lipoprotein (a) contributes to the development and progression of atherosclerotic cardiovascular disease, but awareness on its role and Lp(a) testing remain limited. Lp(a)-lowering drugs are a potential breakthrough to improve cardiovascular outcomes. shorturl.at/IyjFQ

Lipoprotein (a) contributes to the development and progression of atherosclerotic cardiovascular disease, but awareness on its role and Lp(a) testing remain limited. Lp(a)-lowering drugs are a potential  breakthrough to improve cardiovascular outcomes. shorturl.at/IyjFQ
Giuliano Costa (@costagiuliano90) 's Twitter Profile Photo

Do you need more BE THV sizes?This analysis from the OPERA-TAVI registry showed that the BE Sapien 3 ULTRA Edwards Lifesciences had similar VARC-3 early safety and device success in optimal or intermediate sizing zones 👉 eurointervention.pcronline.com/article/balloo…

Do you need more BE THV sizes?This analysis from the OPERA-TAVI registry showed that the BE Sapien 3 ULTRA <a href="/EdwardsLifesci/">Edwards Lifesciences</a> had similar VARC-3 early safety and device success in optimal or intermediate sizing zones 👉 eurointervention.pcronline.com/article/balloo…
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

This analysis of the OPERA-TAVI registry found SAPIEN 3 Ultra implantation in intermediate sizing zones achieves comparable device success and safety to optimal sizing, with similar annular rupture rates. Giuliano Costa Marco Barbanti ow.ly/sXeU50Vb4RS #EAPCI #TAVI

This analysis of the OPERA-TAVI registry found SAPIEN 3 Ultra implantation in intermediate sizing zones achieves comparable device success and safety to optimal sizing, with similar annular rupture rates. <a href="/costagiuliano90/">Giuliano Costa</a> <a href="/barbanti_marco/">Marco Barbanti</a>
ow.ly/sXeU50Vb4RS
 #EAPCI #TAVI
Marco Barbanti (@barbanti_marco) 's Twitter Profile Photo

Bicuspid Aortic Valve Disease & TAVI. Our new State-of-the-Art Review explores recent advances, challenges, and outcomes of TAVI in bicuspid valve. A must-read for clinicians and researchers! 🔗 academic.oup.com/eurheartj/adva… #Cardiology #TAVI #BicuspidAorticValve #HeartInnovation

Bicuspid Aortic Valve Disease &amp; TAVI. Our new State-of-the-Art Review
explores recent advances, challenges, and outcomes of TAVI in bicuspid valve.
A must-read for clinicians and researchers!
🔗 academic.oup.com/eurheartj/adva…

#Cardiology #TAVI #BicuspidAorticValve #HeartInnovation
European Society of Cardiology Journals (@esc_journals) 's Twitter Profile Photo

Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/Tenm50VSnw7 Rocco Montone EHJ Editor-in-Chief

Bicuspid aortic valve disease: advancements and challenges of transcatheter aortic valve implantation. Read this State-of-the-Art review published in #EHJ 👉 ow.ly/Tenm50VSnw7

<a href="/RoccoMontone/">Rocco Montone</a> <a href="/ehj_ed/">EHJ Editor-in-Chief</a>